Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution Crystallization. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103694230A reveals amino acid eutectic purification for Canagliflozin. Achieve <0.5% alpha-impurity with scalable, cost-effective pharmaceutical intermediate solutions.
Patent CN102391145B details a water-based recrystallization method for ubenimex intermediates, offering high purity and cost-effective manufacturing solutions.
Novel chiral resolution patent CN103086877B enables high-purity pharmaceutical intermediates with reduced costs and scalable production for global supply chains.
Patent CN104030996B details a novel Valsartan refining method ensuring high optical purity and yield. Discover cost-effective supply chain solutions for chiral API production.
Patent CN1027503C details a superior crystalline salt form of 4-(di-n-propyl)amino-6-aminocarbonyl-1,3,4,5-tetrahydrobenzo[cd]indole, offering enhanced purity and scalable manufacturing for CNS drug development.
Patent CN101531647B details a safe resolution method for Ramelteon intermediates. Discover cost-effective supply chain solutions and high-purity manufacturing capabilities.
Novel method for beta-lactamase inhibitor intermediate chiral impurities. High purity ee>99.5%. Cost-effective supply chain solutions for pharma QC.
Advanced chiral resolution for pyridoindole derivatives offering high optical purity. Discover cost-effective manufacturing and reliable supply chain solutions for pharmaceutical intermediates.
Patent CN112724129A details a novel chiral purification method for moxifloxacin intermediates, offering superior ee values and scalable industrial production for reliable supply chains.
Patent CN101910101A reveals a novel aliphatic hydrocarbon recrystallization method boosting optical purity to >99% ee for pharmaceutical intermediates efficiently.
Patent CN1442407A details a cost-effective resolution method for fexofenadine intermediates, ensuring high purity and scalable supply chain reliability for global pharmaceutical partners.
Patent CN115010686A details a novel resolution for 2-oxabicyclo-[3.3.0]oct-6-en-3-one, offering high purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN1161689A enables high-purity levobupivacaine production with reduced resolving agent usage and improved supply chain reliability for pharmaceutical manufacturers globally.
Advanced resolution method achieving >99% ee for S-3-cyclohexenecarboxylic acid, optimizing Edoxaban intermediate supply chains with cost-effective recycling.
Patent CN101289417B details an advanced purification process for D-3-thioacetyl-2-methylpropionyl-L-proline, offering superior yield and optical purity for captopril manufacturing.
Advanced optical resolution process for 2-methyl-1-(4-trifluoromethylphenyl)-3-pyrrolidine-1-propanone. Enhances purity and supply chain reliability for pharmaceutical manufacturing.
Patent CN103755582A details a novel direct resolution of DL-serine using cyclic phosphates. This report analyzes cost reduction in API manufacturing and supply chain reliability.
Patent CN104151229B details a high-yield resolution process for Levamlodipine intermediates using DMSO-d6, offering significant supply chain stability and purity advantages for pharmaceutical manufacturing.
Patent CN1053431A reveals an advanced method for Fosinopril synthesis, offering improved stereoselectivity and cost reduction in pharmaceutical intermediate manufacturing for global supply chains.
Patent CN113214267B reveals a novel one-step crystallization method for eszopiclone, offering high purity and significant cost reduction in pharmaceutical intermediates manufacturing.